Hematological Malignancies (HM) TRT

Building UVA Comprehensive Cancer Center’s research and clinical strengths, the goal HM TRT is to offer opportunities for academic exchange of ideas and to foster inter-disciplinary collaborations addressing biological, clinical, and population-based questions about hematopoiesis, pathogenesis, and the treatment of hematological malignancies. The HM TRT meets on the third Thursday of each month to discuss current research and identify opportunities for collaboration. Each October, the HM TRT issues an RFA for pilot awards to support hematological malignancy initiatives.

Deadline: Closed (RFA to be released each October).
Contact: Please email Golam Mohi, PhD (gm7sj@virginia.edu) and Francine Garrett-Bakelman, MD (fg5q@uvahealth.org) with any questions and to discuss project alignment.

If you are interested in participating, please email Karolina Ayres at ka3dt@virginia.edu to be added to the appropriate email list.